[N-(D-6-methyl-8-isoergolenyl)-N',N'-diethyl-urea acid maleate (Lysenyl Spofa--a new drug with antiserotonin action].
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D001786:Blood Glucose / Q000032:analysis; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D055598:Chemical Phenomena; D002627:Chemistry, Physical; D004231:Diuresis / Q000187:drug effects; D004285:Dogs; D004357:Drug Synergism; D004622:Embryo, Mammalian / Q000187:drug effects; D005260:Female; D000882:Haplorhini; D006801:Humans; D008238:Lysergic Acid Diethylamide / Q000009:adverse effects / Q000032:analysis / Q000494:pharmacology / Q000627:therapeutic use* / Q000633:toxicity; D008297:Male; D051379:Mice; D009119:Muscle Contraction / Q000187:drug effects; D009184:Mydriatics / Q000494:pharmacology; D011247:Pregnancy; D011817:Rabbits; D051381:Rats; D012702:Serotonin Antagonists; D013874:Thiopental / Q000494:pharmacology; D014599:Uterus / Q000187:drug effects
D000893:Anti-Inflammatory Agents; D001786:Blood Glucose; D009184:Mydriatics; D012702:Serotonin Antagonists; D008238:Lysergic Acid Diethylamide; D013874:Thiopental
Kyselý maleinan N-(D-6-methyl-8-isoergolenyl)-N',N'-diethylmocoviny (Lysenyl Spofa-nové terapeutikum s antiserotononovým úcinkem)